Minnesota Partnership for Biotechnology and Medical Genomics

ROCHESTER, Minn. — Diabetes, stress-induced aging and Alzheimer's disease, immigration-related obesity, and implantable drug testing devices are the targets of the research awards from [...]

ROCHESTER, Minn. ─ Epilepsy, Alzheimer’s disease, osteoporosis, colorectal cancer and bacterial infections are the targets of the research awards from the Minnesota Partnership for [...]

ROCHESTER, Minn. ─ Mayo Clinic scientists have shown that injections of a hunger hormone blocker in mice can halt the typical weight [...]

ROCHESTER, Minnesota: Los científicos de Mayo Clinic demostraron que la inyección de una hormona que bloquea el hambre en ratones es capaz [...]

ROCHESTER, Minn. — Biomedical researchers in Minnesota will be able to use some of the latest high tech research tools thanks to the latest infrastructure [...]

ROCHESTER, Minn. — New treatments and diagnostics for Alzheimer’s and cancer dominate the 2016 research awards recently announced by the

ROCHESTER and MINNEAPOLIS, Minn. — The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $2.5 million to four teams of researchers to support scientific infrastructure used in collaborations between existing researchers at the University of Minnesota and Mayo Clinic. The funding must be used for equipment, software or other technology essential to specific research projects and must be mutually available to the project participants at both institutions. This year’s awards will help investigators target topics ranging from heart disease and cancer to drug development and the microbiome, all key focus areas of research in Minnesota.

Laser-guided Malaria Detectors Smart Socks that Predict Heart Attacks Mouse Avatars to Study Ovarian Cancer